What experts are saying about Cardiology
Cardiology — heart and cardiovascular disease, treatments, devices, and the research advancing cardiac medicine.
“Eli Lilly is developing a one-time PCSK9 gene-editing therapy designed to permanently lower a patient's LDL cholesterol to a range of 20 to 40 mg/dL.”
— Dave Ricks
“Layne Norton states he has a high degree of confidence that ApoB-containing lipoproteins are atherogenic, meaning they contribute to the formation of atherosclerotic plaques.”
— Layne Norton
“The Tite randomized trial found no significant difference in six-month mortality between relaxed potassium supplementation (1.2% mortality) and tight control (1.1% mortality) after coronary bypass surgery.”
— Dr. Anne Coppola
“The scientific confidence in ApoB-containing lipoproteins being atherogenic is based on converging evidence from Mendelian randomization studies and statin trials.”
— Layne Norton
“Sutter Health's chronic disease management program, Sutter Sync, allows for at-home monitoring of patients with hypertension and diabetes.”
— Warner Thomas